Wondering whether Baxter International at around US$19.18 is a bargain or a value trap? This article walks through what the current price might actually imply. The stock has moved sharply in the short ...

Baxter International (BAX) shares are attempting a technical turnaround, breaking a multi-week downtrend that increasingly ...

Baxter International reported first-quarter 2026 results with sales of US$2,701 million, a net loss of US$15 million, and a diluted loss per share of US$0.03, while reaffirming full-year guidance for ...

Artisan Partners, an investment management company, released its “Artisan Mid Cap Value Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The Russell Midcap Value ...

Baxter International Inc. (BAX), headquartered in Deerfield, Illinois, develops and provides a portfolio of healthcare products. With a market cap of $19.5 billion, the company develops, manufactures, ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 2:20 PM EDTCompany ParticipantsKevin Moran - Vice ...

Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW). In ...

Broyhill Asset Management, an investment advisor, released its first quarter 2025 investor letter. A copy of the letter can be downloaded here. Broyhill Partners appreciated 2.8% net of all fees and ...

Baxter stock (NYSE: BAX), a healthcare company, currently trades at $38 per share, more than 50% lower than the level seen in February 2022. BAX stock has fared worse than its peer – Becton, Dickinson ...